​

Funding Round

Series A - Affect Therapeutics

Series A - Affect Therapeutics

Investment Firm

Overview

Affect Therapeutics uses mobile technology to revolutionize stimulant addiction recovery.

Announced Date

Jul 12, 2023

Funding Type

Series A

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Artis Ventures (AV)

Artis Ventures (AV)

Artis Ventures (AV) is a convertible_note and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorLifeArc Ventures
Participant InvestorWhat If Ventures
Participant InvestorCity Light Capital
Participant InvestorArtis Ventures (AV)
Participant InvestorAlleyCorp

Round Details and Background

Affect Therapeutics raised $16000000 on 2023-07-12 in Series A

Affect Therapeutics uses mobile technology to revolutionize stimulant addiction recovery.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 21, 2021
Seed Round - Affect Therapeutics
1-1.0M
Jul 23, 2021
Seed Round - Affect Therapeutics
4-6.0M
Feb 01, 2023
Series A - Affect Therapeutics
4-undefined
Jul 12, 2023
Series A - Affect Therapeutics
6-16.0M

Recent Activity

There is no recent news or activity for this profile.